Ann M. Hanly, Chief Technology Officer at Vir Biotechnology, Inc. (VIR), sold 4,604 shares at $25.97 ($120K) on 2023-02-23, disclosed to the SEC on 2023-02-24.
Open-market sale of $120k VIR by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.97 | 2,302 | $60K | 50.0% |
| 2 | $25.97 | 2,302 | $60K | 50.0% |
| Total | $25.97 avg | 4,604 | $120K | 100% |
| Filing → |
| VIR | SELL | 2024-02-26 | $247K | — | Filing → |
| VIR | SELL | 2023-03-31 | $120K | — | Filing → |
| VIR | SELL | 2022-03-31 | $138K | — | Filing → |